Search results for "Adverse Events"


 
Results 81 - 90 of about 574 for "Adverse Events".
Sort by: Relevance | Newest | Oldest

Active strategy to diagnose PE in COPD inpatients did not improve outcomes

A Spanish trial found that using d-dimer testing and, if positive, a CT pulmonary angiogram to diagnose pulmonary embolism (PE) did not affect risk of death, clot, or readmission in patients hospitalized for exacerbation of chronic obstructive pulmonary disease (COPD).
https://acphospitalist.acponline.org/weekly/archives/2021/10/20/3.htm
20 Oct 2021

Immediate catheter drainage not superior to delayed in infected necrotizing pancreatitis

A trial found that catheter drainage within 24 hours was associated with similar complications but a greater number of interventions compared to drainage that was delayed until the development of walled-off necrosis.
https://acphospitalist.acponline.org/weekly/archives/2021/10/20/4.htm
20 Oct 2021

New therapies for burns, stroke rehab

Recalls, notifications, and approvals.
https://acphospitalist.acponline.org/archives/2021/09/fda-update-new-therapies-for-burns.htm
15 Sep 2021

Risk for adverse outcomes after early-onset MI appears higher in Black patients

Researchers calculated that 45.7% of race-related disparity in major adverse cardiac events after myocardial infarction (MI) among younger and middle-aged patients was due to lower income, highlighting the importance of social determinants of health.
https://acphospitalist.acponline.org/weekly/archives/2021/09/01/3.htm
1 Sep 2021

Neither rate nor type of fluid resuscitation affected outcomes in ICU patients, trial finds

A balanced solution was compared to a 0.9% saline solution in a large trial in Brazilian ICUs that also randomized the same patients to undergo fluid challenges at rates of either 333 mL/h or 999 mL/h.
https://acphospitalist.acponline.org/weekly/archives/2021/08/18/2.htm
18 Aug 2021

Guidelines updated on use of antithrombotics for VTE

CHEST modified its 2016 recommendations on venous thromboembolism (VTE) management, with changes including the addition of cerebral vein thrombosis as a topic and strengthened support for outpatient VTE treatment.
https://acphospitalist.acponline.org/weekly/archives/2021/08/11/2.htm
11 Aug 2021

Mixed results for remdesivir, negative results for canakinumab, and new vaccine information

Remdesivir appeared to be of benefit in one study but was associated with increased length of stay and no improvement in survival in another, an industry-funded trial found no benefit for canakinumab in severe COVID-19, and the FDA noted a possible increased risk for Guillain-Barré syndrome with the Johnson & Johnson (Janssen) vaccine.
https://acphospitalist.acponline.org/weekly/archives/2021/07/21/1.htm
21 Jul 2021

Counting lives saved

Commonly used tallies of medical errors may dramatically overestimate their toll.
https://acphospitalist.acponline.org/archives/2021/07/counting-lives-saved-issues-with-medical-errors.htm
15 Jul 2021

Pacemakers, stents recalled

Recalls, warnings, alerts, and approvals.
https://acphospitalist.acponline.org/archives/2021/07/fda-update.htm
15 Jul 2021

Guidelines suggest fidaxomicin over vancomycin for Clostridioides difficile infection

The Infectious Diseases Society of America and Society for Healthcare Epidemiology of America made three new recommendations in a focused update of their guidelines on Clostridioides difficile infection.
https://acphospitalist.acponline.org/weekly/archives/2021/06/30/4.htm
30 Jun 2021

Result Page: Prev   4   5   6   7   8   9   10   11   12   13   Next